Company profile
GelStat Corporation
OTC: GSAC · Healthcare · Medical - Pharmaceuticals
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 40
v0.1 · 5/100 weight · pillars only
↑ listing tenure, Piotroski F · ↓ filing timeliness, workforce scale
Methodology →Revenue TTM
$379.1k
Rev growth YoY (TTM)
+62.9%
Net income (FY)
—
Employees
2
as of 2026-08-28
Market cap
$185.4k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is GelStat Corporation’s financial profile?
GelStat Corporation has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Akanda Corp.——BioLife Sciences Inc.——Rimrock Gold Corp.——Easy Technologies Inc.——Mystic Holdings, Inc.——Tian'an Pharmaceutical Co., Ltd.——Neighbors
Martin →Key facts
CEOJavier G. Acosta
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersPalm City, FL
ExchangeOTC: GSAC
Employees2
IPO date1996-02-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.